Mediacle Group (MEGR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3 2024 revenue increased to 19.6 MSEK from 16.0 MSEK year-over-year, reflecting a recovery in sales despite macroeconomic headwinds.
EBITDA for Q3 2024 was 6.6 MSEK, down from 7.8 MSEK in Q3 2023, with margin pressure attributed to increased competition and global economic challenges.
Strategic focus remains on long-term sustainable growth, cost control, and operational efficiency to navigate ongoing market volatility.
Financial highlights
Q3 2024 net sales: 19.6 MSEK (16.0 MSEK Q3 2023); nine-month sales: 51.7 MSEK (57.2 MSEK 2023).
Q3 2024 EBITDA: 6.6 MSEK (7.8 MSEK Q3 2023); nine-month EBITDA: 18.7 MSEK (31.6 MSEK 2023).
Q3 2024 net income: 3.3 MSEK (-0.9 MSEK Q3 2023); nine-month net income: 5.4 MSEK (4.0 MSEK 2023).
Cash and cash equivalents at period end: 113.4 MSEK (98.3 MSEK Q3 2023).
Equity as of September 30, 2024: 109.9 MSEK (101.2 MSEK Q3 2023).
Outlook and guidance
Continued focus on efficiency, customer engagement, and investment in differentiating solutions to drive value and support recovery as market conditions stabilize.
Latest events from Mediacle Group
- Profitability improved despite lower revenue, with strong equity and no dividend for 2025.MEGR
Q4 202527 Feb 2026 - Q3 2025 saw lower revenue but improved operational efficiency and stable net income.MEGR
Q3 202527 Nov 2025 - Q2 2025 saw lower revenue and EBITDA but improved H1 net income and strong financial stability.MEGR
Q2 202529 Aug 2025 - Q2 2024 saw lower revenue and EBITDA, but strong equity and cash support future growth plans.MEGR
Q2 202413 Jun 2025 - Net profit surged in Q1 2025 despite lower sales, reflecting strong operational execution.MEGR
Q1 20256 Jun 2025 - Revenue and EBITDA fell, but net income and cash position strengthened in 2024.MEGR
Q4 20245 Jun 2025